DLA Piper advises MidEuropa on majority stake in MBL Group

DLA Piper has advised MidEuropa, a leading European private equity investor, on the acquisition of a majority stake in MBL Group, a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation and aged care equipment.

As part of the transaction, the INVL Baltic Sea Growth Fund has sold its entire stake, while the Lauritsen family has reinvested a significant amount and Martin Lauritsen will continue to lead the Company as CEO.

Founded in Denmark in 1988 by the Lauritsen family, MBL has grown into the largest European CDMO dedicated to medical mobility devices, including wheelchairs, rollators, aged-care beds and other rehabilitation equipment. The Company employs approximately 1,700 skilled professionals across manufacturing hubs in Europe and Asia serving its global blue-chip clients and holds more than 100 registered patents, underscoring its reputation for engineering excellence and innovation.

MidEuropa is a leading European private equity investor with deep roots in Central Europe and a track record spanning over 25 years. Headquartered in London, with offices in Warsaw and Bucharest, MidEuropa adopts a flexible pan-European and global approach to identify winning investments across the healthcare, technology, services, and consumer sectors and supports them in their growth and international expansion. To date, MidEuropa has raised and managed funds of over EUR6.8 billion and completed 46 investments and over 290 add-on acquisitions across 20 countries.

UK based Co-Head of Private Equity Edward Griffiths and private equity partner Richard McGlasham led a multidisciplinary, cross-border DLA Piper team. The Danish team assisting MidEuropa comprised of Nicholas Lerche-Gredal, Belinda Qehaja, Oliver William Forrester and Anne Christine Fabrin-Brasted and many others across our Denmark, Poland, Beijing and Hong Kong offices.